02171 科济药业－Ｂ
按盘价 
7.060 +0.260 (+3.824%) | 2023/12 - 末期 人民币() | 2022/12 人民币() | 2021/12 人民币() | 2020/12 人民币() | 2019/12 人民币() | |
| 经营活动之现金流量 | -- | (643,048,000) | (512,322,000) | (295,150,000) | (179,004,000) |
| 投资活动之现金流量 | -- | 2,386,990,000 | (2,471,321,000) | (6,897,000) | 82,985,000 |
| 融资活动之现金流量 | -- | (236,514,000) | 2,674,032,000 | 1,302,473,000 | 27,527,000 |
| 现金及等同现金之增加/(减少) | -- | 1,507,428,000 | (309,611,000) | 1,000,426,000 | (68,492,000) |
| 期初之现金及现金等价物 | -- | 691,284,000 | 1,042,969,000 | 96,476,000 | 163,553,000 |
| 汇率变动之影响 | -- | 69,324,000 | (42,074,000) | (53,933,000) | 1,415,000 |
| 其他 | -- | 0 | 0 | 0 | 0 |
| 期末之现金及现金等价物 | -- | 2,268,036,000 | 691,284,000 | 1,042,969,000 | 96,476,000 |
| 备注： | 实时报价更新时间为29/05/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -747,794,000 |
| 增长率 | -16.190% |
| 每股盈利/(亏损) | RMB -1.340 |
| 每股账面资产净值 (¥) | RMB 3.130 |